Karen E. Roder
Impact in
- Neurology top 5%
- Barrier Structure and Function Studies
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
-
- Neuroscience and Neuropharmacology Research 4
-
- Pharmacological Effects and Toxicity Studies 2
- Neonatal and fetal brain pathology 1
- Co-authors
- Paul R. Lockman (4 shared papers)Thomas J. Abbruscato (5 shared papers)David D. Allen (3 shared papers)Russell J. Mumper (2 shared papers)Joanna M. Koziara (2 shared papers)Tianzhi Yang (3 shared papers)Moses O. Oyewumi (1 shared paper)Jennifer R. Paulson (3 shared papers)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (4 papers)Pharmaceutical Research (2 papers)Journal of Neurochemistry (1 paper)Journal of Controlled Release (1 paper)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- United States
In The Last Decade
Karen E. Roder
9 papers receiving 656 citations
Peers
Comparison fields: 5 of 77
- Neurology 165
- Pharmaceutical Science 99
- Biomaterials 152
- Cellular and Molecular Neuroscience 94
- Health, Toxicology and Mutagenesis 51
Countries citing papers authored by Karen E. Roder
This map shows the geographic impact of Karen E. Roder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen E. Roder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen E. Roder more than expected).
Fields of papers citing papers by Karen E. Roder
This network shows the impact of papers produced by Karen E. Roder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen E. Roder. The network helps show where Karen E. Roder may publish in the future.
Co-authors
The 14 scholars most cited alongside Karen E. Roder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 227 | |
| 2 | 2008 | 108 | |
| 3 | 2003 | 85 | |
| 4 | 2004 | 67 | |
| 5 | 2003 | 57 | |
| 6 | 2001 | 48 | |
| 7 | 2007 | 44 | |
| 8 | 2005 | 38 | |
| 9 | 2006 | 32 |
About Karen E. Roder
Karen E. Roder is a scholar working on Cellular and Molecular Neuroscience, Pediatrics, Perinatology and Child Health, Neurology, Nutrition and Dietetics and Oncology, having authored 9 papers that have together received 706 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (4 papers), Drug Transport and Resistance Mechanisms (2 papers), Barrier Structure and Function Studies (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Nicotinic Acetylcholine Receptors Study (2 papers), Cannabis and Cannabinoid Research (1 paper), Biochemical Analysis and Sensing Techniques (1 paper) and Neonatal and fetal brain pathology (1 paper). The work is most often cited by research in Neurology (165 citations), Pharmaceutical Science (99 citations), Biomaterials (152 citations), Cellular and Molecular Neuroscience (94 citations) and Health, Toxicology and Mutagenesis (51 citations). Karen E. Roder has collaborated with scholars based in United States. Frequent co-authors include Paul R. Lockman, Thomas J. Abbruscato, David D. Allen, Russell J. Mumper, Joanna M. Koziara, Tianzhi Yang, Moses O. Oyewumi, Jennifer R. Paulson, Thomas Thekkumkara and David D. Allen. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Pharmaceutical Research, Journal of Neurochemistry, Journal of Controlled Release and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.